International Society of Oncology Pharmacy Practitioners (ISOPP) position statement: Role of the oncology pharmacy team in cancer care

Holle L. M., Bilse T., Alabelewe R. M., Kintzel P. E., Kandemir E. A., Tan C. J., ...More

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, vol.27, no.4, pp.785-801, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 27 Issue: 4
  • Publication Date: 2021
  • Doi Number: 10.1177/10781552211017199
  • Journal Name: JOURNAL OF ONCOLOGY PHARMACY PRACTICE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, International Pharmaceutical Abstracts, MEDLINE
  • Page Numbers: pp.785-801
  • Keywords: Oncology pharmacy, technician, patient care, practice management, research, DRUG-INTERACTIONS, ORAL CHEMOTHERAPY, CLINICAL PHARMACISTS, COST AVOIDANCE, IMPACT, MANAGEMENT, SAFETY, INTERVENTIONS, THERAPY, PREVALENCE
  • Hacettepe University Affiliated: Yes

Abstract

The Oncology Pharmacy Team (OPT), consisting of specialty-trained pharmacists and/or pharmacy technicians, is an integral component of the multidisciplinary healthcare team (MHT) involved with all aspects of cancer patient care. The OPT fosters quality patient care, safety, and local regulatory compliance. The International Society of Oncology Pharmacy Practitioners (ISOPP) developed this position statement to provide guidance on five key areas: 1) oncology pharmacy practice as a pharmacy specialty; 2) contributions to patient care; 3) oncology pharmacy practice management; 4) education and training; and 5) contributions to oncology research and quality initiatives to involve the OPT. This position statement advocates that: 1) the OPT be fully incorporated into the MHT to optimize patient care; 2) educational and healthcare institutions develop programs to continually educate OPT members; and 3) regulatory authorities develop certification programs to recognize the unique contributions of the OPT in cancer patient care.